17. Carroll, R. G., T. E. Lohmeier, and A. J. Brown. Chronic 39.
angiotensin infusion decreases renal norepinephrine overflow in
conscious dogs. Hypertension Dallas 6: 675-681, 1984.
18. Carroll, R. G., T. E. Lohmeier, and A. J. Brown. Disparity 40.
between renal venous norepinephrine and renin responses to
sodium depletion. Am. J. Physiol. 254 (Renal Fluid Electrolyte
Physiol. 23): F754-F761, 1988. 41.
19. Chapleau, M. W., G. Hajuczuk, and F. M. Abboud. Resetting of the arterial baroreflex: peripheral and central mechanisms. In: Reflex Control of the Circulation, edited by I. H. 42.
Zucker and J. P. Gilmore. Boston, MA: CRC, 1991, p. 165-194.
20. Choi-Kwon, S., and A. J. Baertschi. Splanchnic osmosensation and vasopressin: mechanisms and neural pathways. Am. J.
Physiol. 261 (Endocrinol. Metab. 24): E18-E25, 1991. 43.
21. Choi-Kwon, S., R. McCarty, and A. J. Baertschi. Splanchnit control of vasopressin secretion in conscious rats. Am. J.
Physiol. 259 (Endocrinol. Metab. 22): E19-E26, 1990. 44.
22. Cody, R. J., K. W. Franklin, J. Kluger, and J. H. Laragh.
Mechanisms governing the postural response and baroreceptor
abnormalities in chronic congestive heart failure: effects of acute 45.
and long-term converting enzyme inhibition. Circulation 66:
135-142,1982.
23. Cody, R. J., and J. H. Laragh. Use of captopril to estimate 46.
renin-angiotensin-aldosterone activity in the pathophysiology of
chronic heart failure. Am. Heart J. 104: 1184-1189, 1982. 47.
24. Cornish, K. G., and J. P. Gilmore. Sino-aortic denervation in
the monkey. J. Physiol. Lond. 360: 423-432, 1985.
25. Cowley, A. W., Jr. Long-term control of arterial pressure.
Physiol. Reu. 72: 231-300, 1992.
26. Cowley, A. W., Jr., and J. W. DeClue. Quantification of
baroreceptor influence on arterial pressure changes seen in
48.
primary angiotensin-induced hypertension in dogs. Circ. Res. 39:
779-787,1976.
27. Cowley, A. W., Jr., and T. E. Lohmeier. Changes in renal
vascular sensitivity and arterial pressure associated with sodium
intake during long-term intrarenal norepinephrine infusion in 49.
dogs. Hypertension Dallas 1: 549-558, 1979.
28. Cowley, A. W., Jr., and R. J. Roman. Rena1 dysfunction in
50.
essential hypertension-implications of experimental studies. Am.
J. Nephrol. 3: 59-72, 1983.
29. Cowley, A. W., Jr., M. M. Skelton, and D. C. Merrill. Are
hypertensive effects of aldosterone, angiotensin, vasopressin,
and norepinephrine chronically additive? Hypertension Dallas 8: 51.
332-343,1986.
30. Cox, B. F., and V. S. Bishop. Neural and humoral mechanisms
of angiotensin-dependent hypertension. Am. J. PhysioL. 261
(Heart Circ. Physiol. 30): H1284-H1291, 1991.
31. DiBona, G. F. Sympathetic neural control of the kidney in 52.
hypertension. Hypertension Dallas 19, Suppl. I: 128-135, 1992.
32. DiBona, G. F., and L. L. Sawin. Renal nerve activity in
conscious rats during volume expansion and depletion. Am. J. 53.
Physiol. 248 (Renal Fluid Electrolyte Physiol. 17): F15-F23,
1985.
33. Dusing, R., G. Kayser, S. Wagner, H. Scherf, K. Glanzer, 54.
H. G. Predel, and H. J. Kramer. Baroreflex resetting and
sensitivity in normal subjects: effects of pharmacologic inhibi- 55.
tion of the angiotensin I converting enzyme. Am. J. Cardiol. 59:
50D-54D, 1987.
34. Ebert, T. J. Captopril potentiates chronotropic baroreflex re- 56.
sponses to carotid stimuli in humans. H.ypertension Dallas 7:
602-606,1985.
35. Eckberg, D. L., and P. Sleight. Human BarorefZexes in Health
and Disease. New York: Clarendon, 1992. 57.
36. Edvinsson, L., R. Hakanson, C. Wahlestedt, and R. Uddman. Effects of neuropeptide Y on the cardiovascular system.
Trends PharmacoL. Sci. 8: 231-235, 1987.
37. Esler, M., G. Jennings, G. Lambert, I. Meredith, M. 58.
Horne, and G. Eisenhofer. Overflow of catecholamine neurotransmitters to the circulation: source, fate and functions.
Physiol. Reu. 70: 963-985, 1990. 59.
Fejes-Toth, G., A. Naray-Fejes-Toth, and D. Ratge. Evidence against role of antidiuretic hormone in support of blood
pressure during dehydration. Am. J. Physiol. 249 (Heart Circ.
Physiol. 18): H42-H48, 1985.
